Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | PHVS | ZBIO | ||
| Company | Rapport Therapeutics Inc | Pharvaris N.V. | Zenas Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 28.94 | 26.58 | 25.20 | ||
| High | 30.10 | 26.64 | 25.64 | ||
| Low | 28.40 | 25.79 | 24.50 | ||
| Latest | 29.65 | 25.84 | 25.26 | ||
| Change | +0.31 | -0.96 | -0.56 | ||
| % Change | +1.06% | -3.58% | -2.17% | ||
| Volume | 316,300 | 125,600 | 314,800 | ||
| 20-Day Average Volume | 300,165 | 112,325 | 762,520 | ||
| Previous Close | 29.34 | 26.80 | 25.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.64 | 27.16 | 25.08 | ||
| 20-Day Raw Stochastic | 70.59% | 22.70% | 58.51% | ||
| 20-Day Relative Strength | 54.49 | 45.32 | 50.13 | ||
| Weighted Alpha | +94.10 | +47.79 | +339.93 | ||
| Today's Opinion | 100% Buy | 64% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.51% since 02/26/26 | -7.71% since 02/26/26 | -4.17% since 02/26/26 | ||
| Low | 26.48 on 03/03/26 | 25.79 on 03/05/26 | 24.18 on 03/04/26 | ||
| High | 30.10 on 03/05/26 | 28.61 on 03/02/26 | 26.86 on 03/04/26 | ||
| 1-Month | |||||
| %Chg | +16.05% since 02/05/26 | +2.78% since 02/05/26 | +20.23% since 02/05/26 | ||
| Low | 25.78 on 02/09/26 | 25.39 on 02/06/26 | 20.56 on 02/11/26 | ||
| High | 31.50 on 02/23/26 | 28.99 on 02/23/26 | 29.55 on 02/17/26 | ||
| 3-Month | |||||
| %Chg | +0.51% since 12/05/25 | -2.20% since 12/05/25 | -35.86% since 12/05/25 | ||
| Low | 25.21 on 02/05/26 | 23.15 on 12/10/25 | 13.50 on 01/05/26 | ||
| High | 32.36 on 12/23/25 | 28.99 on 02/23/26 | 44.60 on 12/24/25 | ||
| 6-Month | |||||
| %Chg | +106.48% since 09/05/25 | +12.10% since 09/05/25 | +23.16% since 09/05/25 | ||
| Low | 22.06 on 09/11/25 | 20.65 on 10/17/25 | 13.50 on 01/05/26 | ||
| High | 42.27 on 09/08/25 | 29.80 on 12/04/25 | 44.60 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,398,374 | 1,401,372 | 1,385,992 | ||
| Shares Outstanding, K | 47,661 | 52,290 | 53,679 | ||
| Annual Sales | 0 | 0 | 5,000,000 | ||
| Annual Net Income | -78,310,000 | -145,240,000 | -156,990,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -26,930,000 | -43,410,000 | -52,220,000 | ||
| 60-Month Beta | 1.51 | -2.78 | -1.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 11/06/25 | -0.70 on 11/12/25 | -1.22 on 11/12/25 | ||
| Latest Earnings Date | 03/10/26 | 04/06/26 | 03/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 12/24/19 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||